Navigation Links
Digirad Corporation to Receive Frost & Sullivan 2007 North American Award for Product Strategy
Date:2/6/2008

Digirad Recognized for Imaging Platform and Successful Mobile Imaging

Services Network

POWAY, Calif., Feb. 6 /PRNewswire-FirstCall/ -- Digirad Corporation (Nasdaq: DRAD), a leading provider of medical diagnostic imaging systems and services to physicians' offices, hospitals and imaging centers, today announced it is the recipient of Frost & Sullivan's 2007 North American Nuclear Medicine Equipment Product Line Strategy Award.

Travis Chong, research analyst for Frost & Sullivan, remarked that the award recognizes Digirad for its strategy in developing a common dedicated SPECT camera platform based on solid-state technology that offers single, dual and triple-head configurations that can accommodate physicians' workflow needs; for example, using a three-head XPO system for faster image processing and higher throughput of patients. The XPO systems can handle patients weighing up to 500 pounds and may also be configured for fixed or mobile operation, with the mobile configuration providing the ideal solution to service multiple sites enhancing asset utilization or developing outreach activities to increase revenues.

"With the integration of the XPO feature into its entire Cardius line, Digirad has developed a scalable system platform designed to accommodate consumer needs as their operations develop over time," said Chong.

The award also recognizes Digirad's successful establishment of a growing network that offers in-office mobile imaging services through its Digirad Imaging Solutions (DIS) division. Digirad was the first to develop and commercialize solid-state nuclear imaging systems and, based on growing demand for diagnostic imaging services, extended its operations by offering m
'/>"/>

SOURCE Digirad Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Finkelstein Thompson LLP Announces Filing of Securities Fraud Class Action Against CellCyte Genetics Corporation
2. DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results
3. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
4. CV Therapeutics and Medlogics Device Corporation Sign Licensing Agreement for CVTs Innovative Stent Coating Technology
5. DURECT Corporation Invites You to Join Its Fourth Quarter 2007 Earnings Conference Call
6. Baxa Corporation Launches New Web Site
7. CuraGen Corporation Receives Notification from NASDAQ
8. Healionics Corporation Completes Series A Financing
9. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2008
10. China Bionanometer Industries Corporation Announces Record Second Quarter 2007 Results
11. Hagens Berman Sobol Shapiro: Lawsuit Filed Against CellCyte Genetics Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , December 23, 2014 ... Algeria , out today and available for free download ... actors driving change and growth in the sector today. ... scored notable successes has been in developing a homegrown pharmaceutical ... percent local production still remains some way off. A cursory ...
(Date:12/22/2014)... ROCKVILLE, Md. , Dec. 22, 2014 ... MKT: SYN), a developer of pathogen-specific therapies ... focus on protecting the microbiome, today announced ... a Phase 1a clinical trial of SYN-004, ... the prevention of Clostridium difficile (C. ...
(Date:12/22/2014)... 2014 The American Journal ... original research, reviews and editorials addressing developments and ... today published a provocative article exploring the role ... and potential treatment of prostate cancer. , ... proposes the possibility that there could be a ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one ... of Nick Maroulis, Pharm.D. to the newly created position ... In this position, Dr. Maroulis will continue to manage ... of our multi-site pharmacies as the company expands. Dr. ... that time he has served in many different capacities ...
Breaking Biology Technology:PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2
... - Ondine Biopharma Corporation,(TSX: OBP; AIM: OBP), ... announced that its Chief Technology,Officer, Dr. Nicolas ... 28th Annual,Canaccord Adams Global Growth Conference at ... 12th, 2008 at 1:00 p.m. Eastern Time., ...
... has launched a commercial biorepository service, bioVAULT, which stores, manages ... scientific and pharmaceutical companies investigating new drug and diagnostic development. ... ... 5, 2008 -- XTELL announced today the launch of its ...
... seeking financing/strategic ... alternatives, ... announced today that the Company is focusing its,day-to-day operations exclusively on ... Company,s remaining cash,resources, the Company,s employees were released from employment, except,for ...
Cached Biology Technology:Ondine to Present at Canaccord Adams 28th Annual Global Growth Conference 2XTELL Launches its Commercial Biorepository Services for Research and Pharmaceutical Companies 2Arbios Announces It Has Suspended Operations 2Arbios Announces It Has Suspended Operations 3Arbios Announces It Has Suspended Operations 4Arbios Announces It Has Suspended Operations 5
(Date:11/21/2014)... 2014 C-Labs LLC, a leading provider of ... (IoT), today announced the appointment of John Traynor ... a strategic advisor to the firm, Mr. Traynor will ... is based out of the C-Labs office in ... Chris Muench , Chief Executive Officer. Photo ...
(Date:11/18/2014)... , Nov. 18, 2014  The Secure Identity ... Association today jointly announce the formation of The ... of its Identity and Biometric Entry and ... Framework received official support from BORDERPOL, the international ... improve and provide expertise regarding border security, traveler ...
(Date:11/18/2014)... BETHESDA, Md. , Nov. 17, 2014 The ... European and U.S. regulatory agencies will speak and at least ... Quality Metrics Conference at the Omni Shoreham Hotel in ... is pleased once again to have significant support from the ... and Europe in our effort to ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
... become more educated, studies have demonstrated that they tend to ... nutrients. They also pay more. In a study published in ... American Dietetic Association , researchers from the University of Washington ... of 164 adults in the Seattle, Washington area. The ...
... plants are constantly confronted with adverse environmental conditions, lowering ... use specialized signals, called stress hormones, to sense difficult ... Of the various stress hormones, abscisic acid ... last 30 years as the key hormone that helps ...
... readily available to health officials and businesses, a Purdue ... amounts of melamine in infant formula. Using infrared ... professor of food science, was able to detect melamine ... about five minutes or less. Melamine, a synthetic chemical ...
Cached Biology News:People of higher socioeconomic status choose better diets -- but pay more per calorie 2Synthetic chemical offers solution for crops facing drought 2Synthetic chemical offers solution for crops facing drought 3Researcher: Lasers used to detect melamine in baby formula 2
... Competitor Assay Kits are ideal for ... binding compounds using fluorescence polarization (FP) ... of glutathione transferase to the ligand ... [PR-LBD(GST)] and a proprietary, fluorescently-tagged progesterone ...
... vectors combine the proven features of the ... and provides all of the benefits and ... vector backbone. The pTriEx vectors have been ... genes in all three expression systems. In ...
Rabbit polyclonal to Shigella Immunogen: Mixture of S. boydii, S. flexneri & S. dysenteriae....
... Cell Identification Kit. ALDEFLUORs ... substrate for the enzyme ... is highly expressed in ... making ALDH an extremely ...
Biology Products: